Breaking News

Flamma, Gilead Continue Mfg. Partnership for Veklury

Flamma will continue to use its sites in Italy and China to support Gilead's network of manufacturers contributing to supply of Veklury.

By: Contract Pharma

Contract Pharma Staff

Flamma SpA, a CDMO that develops, manufactures, and commercializes small molecule APIs, has entered into an agreement with Gilead to be part of the network of manufacturers contributing to the Veklury (remdesivir) supply chain. Flamma will continue to use its sites in Italy and China to support the need for necessary compounds in the fight against COVID-19. “Covid-19 hit very close to home as Flamma is located in the Bergamo, one of the most affected areas in Italy. Our facility in Dalian, C...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters